Improve Medical released its 2026 interim report, with net profit attributable to the parent company of 30.8149 million yuan, an increase of 15.5484 million yuan compared with the same period last year, up 101.85% year on year, achieving growth for two consecutive years. The company's total operating revenue was 215 million yuan, and net cash inflow from operating activities was 56.7587 million yuan, up 231.77% year on year. The latest asset-liability ratio was 31.64%, down 9.69 percentage points from the same period last year; the gross margin was 47.70%, up 6.33 percentage points year on year, achieving growth for three consecutive years. Diluted earnings per share were 0.10 yuan, up 100% year on year.
Guangzhou Improve Med InstrumentNet profit up 101.85% year on year, with improved margins and lower leverage.